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Take home points 
 
• The number of ideal cardiovascular health metrics is a strong predictor of CVD incidence 
• Meeting 5-7 ideal metrics is associated with the lowest rate of CVD incidence 
• Meeting less than 5 ideal metrics also protects against CVD incidence 
• Older individuals having a higher number of ideal CVH metrics was related with weaker 
protection of CVD events 
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Abstract 
In 2010 the American Heart Association proposed a definition of ideal cardiovascular health (CVH) 
including seven behaviours and health factors that they called “Life’s Simple 7”. The aim of the 
study was to investigate the association between ideal CVH metrics and incident CVD by 
conducting a systematic review and meta-analysis of prospective cohort studies. We searched the 
MEDLINE, EMBASE, and CINAHL databases for studies that met the following criteria: i) 
prospective studies conducted in adults, ii) with outcome data on CVD incidence, and iii) a measure 
of ideal cardiovascular health metrics. Eight studies (219,050 adults) were included in this analysis. 
Compared to those adults who met  0-2 of the ideal CVH metrics (high risk individuals), a 
significantly lower hazard for incidence CVD was observed on those who had 3-4 points for the 
ICH metrics (Hazard Ratio [HR]=0.54, 95% CI 0.48-0.59) and 5-7 points (HR: 0.28, 95% CI 0.23-
0.33). Weaker associations were observed in studies with older individuals, therefore suggesting 
there is a positive relationship between age and HR. Although meeting 5-7 metrics is associated 
with the lowest hazard for CVD incidence, meeting 3-4 metrics still offer an important protective 
effect for CVD. Therefore, a realistic goal in general population in the short term could be to 
promote at least an intermediate ideal CVH profile (3-4 metrics). 
 
Key words. Risk factors; Health behaviors; Life’s Simple 7; Stroke; Cardiac Prevention. 
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Introduction 
Cardiovascular disease (CVD) is responsible for the largest proportion of global premature non-
communicable chronic disease (NCD) mortality 1; Increasing evidence suggests that shared lifestyle 
and biologic risk factors, including unhealthy diet, physical inactivity, hypertension, obesity, and 
dyslipidemia increase the risk of incident CVD 2, 3. The World Health Organization have given 
special emphasis on reducing these shared risk factors as a strategy for reducing CVD risk 4 and 
overall premature NCD mortality.  
 In this context, The American Heart Association (AHA) proposed a definition of ideal 
cardiovascular health (CVH) metrics, also known as Life’s Simple-7, which include four favourable 
health behaviours (never smoker or quit, ideal body mass index, meeting physical activity 
guidelines and consumption of a diet that promotes cardiovascular health) and three health factors 
(untreated total cholesterol <200 mg/dl, untreated blood pressure <120/80 mm/Hg, and absence of 
diabetes mellitus), in addition to the absence of established clinical CVD diagnosis; based on these 
an ideal CVH score was derived and individuals were categorized as: poor, intermediate and ideal 
CVH 5 with only 0.5% to 15% of the U.S adult population meeting the ideal CVH criteria 6. 
 A recent meta-analysis suggested a reduction in the risk of mortality in a dose-response 
fashion, indicating that even minor improvements in cardiovascular health are associated with 
significant CVD death risk reductions 6. These results are of major public health importance 
because an ideal CVH profile (i.e. meeting 5-7 metrics) is associated with 25% lower CVD health 
care costs, compared against those with a lower ideal CVH score.7 Another recent meta-analysis by 
Fang et al, concluded that individuals meeting more ideal CVH metrics at baseline have a 
significantly lower CVD or all-cause mortality than those with a less ideal CVH profile 8. However, 
Fang and colleagues did not include several large prospective studies 9-12. In addition, the authors 
did not analyze the association between individual ideal CVH metrics and mortality and the impact 
of achieving 3-4 metrics (intermediate ideal CVH profile), something that could probably be 
considered a more realistic goal for the population at large and a marker for successful patient 
Page 4 of 34Mayo Clinic Proceedings
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
 5
engagement in CVD risk reduction interventions. Therefore, the aim of the study was to investigate 
the associations between meeting individual and combined ideal CVH metrics and incident CVD by 
conducting a systematic review and meta-analysis of prospective cohort studies. 
 
Materials and Methods 
A systematic review and meta-analysis was conducted following the guidelines of the Cochrane 
Collaboration 13 and the most recent AHA Scientific Statement on Methodological Standards for 
Meta-Analyses 14. Findings were reported according to the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses (PRISMA) 15. The review was registered in PROSPERO 
(registration number: CRD42017073875). 
Data Sources and Searches 
 An electronic search in three databases was performed: MEDLINE (PubMed and OvidSP) 
(January 2010- 09 July 2017), EMBASE (January 2010- 09 July 2017), and CINAHL (January 
2010- 09 July 2017). The search strategies for all databases queried can be found in the 
Supplementary Materials appendix. In PubMed, comprehensive free text and MeSH synonyms for 
“American Heart Association 2020”, “Cardiovascular Health”, “Life’s Simple 7”, “ideal 
cardiovascular health”, “AHA 2020” and “Cardiovascular Disease” were used. Only English 
articles were included. In addition, the reference lists and related links of retrieved articles were 
examined to detect studies potentially eligible for inclusion.  
Study selection 
 The a priori inclusion criteria for this meta-analysis were as follows: i) participants: adult 
(e.g. ≥ 18 years of age) population without history of myocardial infarction or stroke; ii) type of the 
study: observational studies analyzing ideal CVH, as defined by the AHA, and termed as: 
“Cardiovascular Health” or “Ideal Cardiovascular Health”; and iii) main outcomes: incident CVD. 
Two authors (AG-H & RR-V) independently assessed the electronic search results. When an article 
title seemed relevant, the abstract was reviewed for eligibility. When more information was 
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required, the full text of the article was retrieved and appraised for possible inclusion. Any 
differences between the two authors were discussed and, if necessary, a third author was referred to 
for arbitration (JMS). Reasons for exclusion of identified articles were recorded in all cases.  
Data extraction and risk of bias 
 Data were extracted from all articles that met selection criteria and deemed appropriate for 
detailed review by two authors. Details of individual studies were collected and characterized on the 
basis of study design, participants, region of study of each study and hazard ratios (HR) (and their 
associated 95% CIs).  
 Two authors independently (AG-H & RRV) assessed the quality of included articles 
according to the Newcastle-Ottawa quality scale (NOS) 16. This scale contains 8 items categorized 
into 3 domains (selection, comparability, and exposure). A star system is used to enable semi-
quantitative assessment of study quality; such that the highest-quality studies are awarded a 
maximum of 1 star per item with the exception of the comparability domain, which allows 
allocating 2 stars. Thus, the score ranges from 0 to 9 stars. 
Patient involvement 
 Due to the nature of the study, no participants were involved in the systematic review and 
meta-analysis. No patients were involved in the development of the research question or outcome 
measures, nor were they involved in the design, implementation, recruitment, or conduct of the 
study. No patients were asked to advise on interpretation or writing up of results. There are no plans 
to disseminate the results of the research to study participants. 
Data Synthesis and Analysis 
 The a priori plan was to conduct a one-step individual participant data meta-analysis. All 
analyses were carried out using STATA (version 14.0, STATA Corporation, College Station, Tex). 
Hazard Ratios (HR) with associated 95% CIs were extracted from studies for each outcome of 
interest (used to estimate the risk for CVD incidence for individual and number of health metrics) 
and pooled HR was then calculated using random effect (DerSimonian and Laird) models. The 
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likelihood approach with random effects was used to better account for the imprecision in the 
estimate of between-study variance 17. When studies presented several statistical risk-adjustment 
models, we only considered HR associated with the statistical models that contained the fewest 
number of additional covariates to improve comparability across studies.  
 The percentage of total variations across the studies due to heterogeneity (Cochran’s Q-
statistic) 18 was estimated using I2, considering I2 values of <25%, 25–50%, and >50% as small, 
medium, and large amounts of heterogeneity respectively 19.  
 Small-study effects biases were assessed using the extended Egger's test 20 and presence of 
publication bias was investigated graphically by funnel plots.  
 Sensitivity analysis was conducted to assess the robustness of the summary estimates in 
order to determine whether or not a particular study accounted for the heterogeneity. Thus, in order 
to examine the effects of each result from each study on the overall findings, results were analyzed 
with each study deleted from the model once. 
 Finally, random-effects meta-regression analyses were used to separately evaluate whether 
results were different by mean age of participants at baseline 21. 
 
Results 
Literature Search 
 The electronic search strategy retrieved 812 articles. After removing duplicate references 
and based on title and abstract, 22 articles were read in full. The reasons for exclusion based on full 
text were (n=10): (i) inappropriate study design (4 articles); (ii) inappropriate outcome (1 article); 
(iii) inappropriate exposure measurement (2 articles); (iv) duplicate data (2 articles); and (v) study 
population (1 article). Finally, twelve studies 9-12, 22-29 met our inclusion criteria and were included 
in the systematic review and eleven in the meta-analysis (Figure 1). One study was not included in 
the analysis due to lack of data availability based on the ideal CVH categorization 28. 
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***Figure 1 about here*** 
 
Study Characteristics 
Table 1 summarizes the characteristics of the twelve included studies. All of them were prospective 
observational studies, and were published from 2011 to 2017. The studies included 219,050 
participants. Sample sizes ranged from 2,392 11 to 91,598 participants 26. Participants were mostly 
women (55.1%, 120,697 women) and the average age of the participants was 59.4 years old. 
Studies were conducted in the USA 10-12, 22-24, 27-29, China 26, France 9, and Europe 25.  
 The percentage of the total sample having an ideal CVH profile (≥ 5 metrics or >10 points) 
was low (13.2 ± 15.1 %; n= 28,914). Those with an intermediate ideal CVH profile (3-4 metrics or 
5-9 points) represented 49.6 ± 17.1 % of the total sample (n= 108,648). The percentage of 
participants having a poor ideal CVH profile (1-2 metrics or <5 points) was 37.2 ± 26.8% (n= 
81,487). The prevalence of ideal levels for each of the 7 individual ideal CVH metrics at baseline is 
shown in the Supplementary Material section (Figure S1). 
 
Primary outcome 
 The CVD spectrum of outcomes included stroke 9, 10, 22, 24-26, 28, myocardial infarction 22, 26, 
incident heart failure 11, 12, 23, venous thromboembolism 24, 27, coronary heart disease 9, 25, and a 
composite variable of CVD events 22, 24-26. 
Baseline examination (metrics) 
Assessment of smoking habits, body mass index, biochemical parameters (total cholesterol 
and fasting glucose or glycated hemoglobin 25) and blood pressure were carried out using 
standarized protocols, and physical activity used questionnaire-based measures. The instruments 
used to evaluate the diet were as follows: Dong et al. 22 used a structured in-person interview with 
questions adapted from the National Cancer Institute Food Frequency questionnaire; Folsom´s 
studies 23, 24, 29 assessed dietary intake by a slightly modified 66-item Harvard food frequency 
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questionnaire; Gaye et al. 9 used a brief food frequency questionnaire without information about 
fiber and sodium intake; Kulshreshtha et al.10 and Olson et al.27 applied a food frequency 
questionnaire adapted for the REGARDS study; Lachman et al. 25 used dietary information obtained 
from a 130-item food frequency questionnaire; Miao et al. 26 used salt intake as a proxy for dietary 
behaviour; Nayor et al. 11 assessed dietary intake using a food frequency questionnaire (≥ 4.5 
cups/day fruits and vegetables, ≥ 2x3.5 oz servings/week of fish, ≥ 3x1 oz servings/day of fiber-rich 
whole grains, < 1500 mg/d of sodium, and < 36 oz/week of sugar sweet beverages); Ogunmoroti et 
al. 12 used a validated 120-item food frequency questionnaire; finally, Ommerborn et al. 28 applied a 
validated food frequency questionnaire adapted for adults living in the Mississippi Delta Region. 
Risk of bias 
 All twelve studies met at least seven NOS criteria and were considered to have adequate 
methodological quality. The average total score was 7.7 with a range from 7 to 8 (Table 1).  
Association between ideal CVH metrics and incident CVD  
Overall, compared to individuals with a poor ideal CVH profile (meeting only 1-2 metrics), 
incident CVD was lower in those who had an ideal CVH profile (meeting 5-7 metrics) (HR=0.28, 
0.23-0.33, P<.001; I2 = 70.5%) and in those with an intermediate ideal CVH profile (3-5 metrics) 
(HR=0.53, 0.47-0.59, P<.001; I2 = 71.2%).  
Analyzing each incident CVD outcome, individuals who have an ideal or intermediate ideal 
CVH profile have fewer odds of having myocardial infarction (Ideal, HR=0.24, 0.15-0.34, P<.001; 
I2 = 0%; Intermediate, HR=0.54, 0.46-0.62, P<.001; I2 = 0%), stroke (Ideal, HR=0.33, 0.21-0.45, 
P<.001; I2 = 52.5%; Intermediate, HR=0.58, 0.44-0.72, P<.001; I2 = 76.8%), incident heart failure 
(Ideal, HR=0.26, 0.15-0.37, P<.001; I2 = 67.1%; Intermediate, HR=0.49, 0.41-0.56, P<.001; I2 = 
26.5%), venous thromboembolism (Ideal, HR=0.48, 0.35-0.61, P<.001; I2 = 0%; Intermediate, 
HR=0.69, 0.52-0.86, P<.001; I2 = 0%), coronary heart disease (Ideal, HR=0.21, 0.05-0.36, P<.001; 
I2 = 0%; Intermediate, HR=0.56, 0.36-0.75, P<.001; I2 = 50.9%), and a composite variable of CVD 
events (Ideal, HR=0.23, 0.13-0.34, P<.001; I2 = 82.0%; Intermediate, HR=0.45, 0.31-0.58, P<.001; 
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I2 = 85.5%) compared to those with a poor ideal CVH profile (Figure 2 and 3). 
 
***Figure 2 about here*** 
***Figure 3 about here*** 
Meta-regression analyses plotting mean age shows that there were significant age effects on 
the HR estimates for overall incident CVD (beta= 0.026; P= .016 and beta= 0.012; P= .042) in the 
ideal and intermediate ideal CVH profile groups, respectively) (Figure 4). 
 
***Figure 4 about here*** 
Publication bias and sensitivity analysis 
When the impact of individual studies was examined by removing studies from the analysis 
one at a time, we observed that the pooled HR estimate remained constant. Evidence suggesting 
publication bias was apparent, according to the Egger test results (P=.562 and P=.836 in ideal and 
intermediate ideal CVH profile groups, respectively). The observed asymmetry in the funnel plots 
indicates the pooled HRs may have been overestimated due to reporting bias. Also, the funnel plots 
for the relationships of ideal CVH metrics and incident CVD were asymmetric (Supplementary 
Material Figure S2). 
 
Discussion 
Our findings suggest a strong inverse association between the number of ideal cardiovascular health 
metrics and incident CVD events. For individuals with an ideal CVH profile (meeting 5-7 metrics) 
an average reduction of 52% to 76% was found for incident CVD. Furthermore, an intermediate 
ideal CVH profile (meeting 3-4 ideal CVH metrics) was also associated with a significant average 
reduction in incident CVD of 31% to 56%. Therefore, for purposes of primary and secondary 
prevention risk, communication could be the promotion of at least achieving an intermediate ideal 
CVH profile.  
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Our meta-regression analysis showed that the CVD protection associated with attaining 
more ideal CVH metrics was lower among older populations. This finding is of special importance 
due to the exponential relationship of age with mortality and CVD events 30. The only study 
included in this meta-analysis addressing elderly individuals reported that attaining more ideal CVH 
metrics is highly beneficial regarding incident CVD risks; this risk reduction was consistent across 
age groups, except for individuals older than 76 years old 9. Therefore, the promotion of ideal CVH 
metrics should occur across population groups and especially in elderly subjects. 
 The results of the present meta-analysis showed that achieving a higher number of ideal 
CVH metrics is related to a lower incidence of CVD. An ideal CVH profile was associated with 
reduced odds of 77% for a composite variable of CVD events, 79% for coronary heart disease, 76% 
for myocardial infarction, 74% for incident heart failure, 67% for stroke and 52% for venous 
thromboembolism. Similarly, an  intermediate profile was associated with reduced odds of 55% for 
the CVD event composite variable, 64% for coronary heart disease, 46% for myocardial infarction, 
43% for incident heart failure, 42% for stroke and 31% for venous thromboembolism. The 
pathogenesis of these various CVD events and the role of traditional cardiovascular risk factors and 
lifestyle behaviors has some commonalities but also some differences. For example, according to 
the INTERHEART Study 31, myocardial infarction is strongly associated with the presence of 
smoking, hypertension, diabetes, and dyslipidemia. Along the same line, the INTERSTROKE 
Study 32 showed that hypertension had a greater association with intracerebral hemorrhage stroke, 
whereas current smoking and diabetes were more associated with ischemic stroke. Also, the 
Framingham Heart Study reported that hypertension can be considered as one of the frequent causes 
of heart failure 33. Regarding venous thromboembolism, obesity is the lifestyle risk factor most 
consistently associated with its incidence 34. Finally, the most common risk factor associated with 
coronary heart disease is smoking, but diabetes, hypertension, smoking, dyslipidemia and obesity 
account for about 85% to 90% of premature coronary heart disease patients 35. 
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The information summarized in this study suggests that a substantial reduction in incident 
CVD can be expected if at least 3-5 ideal CVH behavioural and/or biological metrics are achieved, 
with even larger reductions in CVD incidence associated with meeting more ideal CVH metrics. In 
terms of preventive cardiology practice, achieving an intermediate profile could be a more realistic 
goal for many patients, especially because of the low prevalence of ideal blood pressure (21.1%) 
and diet (4.1%) reported in included studies. A large number of studies have shown that moderate 
physical activity, smoking cessation, and a healthy diet are beneficial for prevention of CVD events 
36. In our review, the mean prevalence of meeting the ideal smoking metric was relatively high 
(68.7%), but in contrast ideal physical activity and diet were low (≈32%). These findings suggest 
that particular efforts in clinical practice should be made in the counselling and promotion of 
physical activity and healthy dietary behaviors 37, aided by linkage to community-based lifestyle 
intervention efforts. If successful, this would have an impact on blood pressure 38, glucose 
homeostasis 39,  and dyslipidemia and therefore in CVD events incidence 40. The U.S. Preventive 
Services Task Force recommends medium- or high-intensity behavioral interventions to promote a 
healthful diet and physical activity and suggests that these interventions may be provided to 
individual patients in primary care settings or in other sectors of the health care system after referral 
from a primary care clinician 41. Previous studies also support the potential of using population-
based strategies targeting multiple risk factors simultaneously to achieve reductions in CVD rates in 
communities 42. 
 
Strength and limitations 
Strengths of this meta-analysis include the relatively large number of participants 
(n=219,050) and the various CVD outcomes studied. However, several limitations must be 
considered when interpreting these findings. First, some of these incident CVD outcomes have a 
somewhat different aetiology, particularly venous thromboembolism. However, the behavioural and 
biologic risk factors included in the AHA ideal CVH profile contribute to increased CVD risk 
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through various shared mechanisms such as inflammation, atherosclerosis and hypercoagulability 6.   
Second, the follow-up of several studies were of limited duration. Third, different studies included 
different sets of covariates and hazards models that could have an impact on CVD incidence. 
Fourth, measurements of diet and physical activity were sometimes not standardized (did not report 
the use of a valid and reliable measure). Fifth, the study included a relatively healthy population 
with lower incident CVD risk. Finally, the composite variable of CVD events varied in the included 
studies and therefore its ethiology and related factors may differ. 
In conclusion, our findings suggested an inverse association between the number of ideal 
CVH metrics (attainment of at least three metrics) and incident CVD. Also, in older individuals 
having a higher number of ideal CVH metrics was related with weaker protection of CVD events. 
This meta-analysis supports the use of the American Heart Association ideal CVH metrics and 
highlights the importance of improving individual health-related behaviours in order to reduce adult 
incident CVD. 
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Figure legend 
Figure 1. Flow chart for identification of trials for inclusion in the meta-analysis. 
Figure 2. Hazard Ratios (95% Confidence Interval) for cardiovascular events for ideal versus poor 
profile. 
Figure 3. Hazard Ratios (95% Confidence Interval) for cardiovascular events for intermediate 
versus poor profile. 
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Figure 4. Association between log hazard ratios of CVD events and age mean at baseline (years). A, 
ideal versus poor profile. B, intermediate versus poor profile. Solid line indicates a linear 
relationship. Size of each data point is proportional to its statistical weight. 
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Figure 1. Flow chart for identification of trials for inclusion in the meta-analysis.  
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Figure 2. Hazard Ratios (95% Confidence Interval) for cardiovascular events for ideal versus poor profile.  
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Figure 3. Hazard Ratios (95% Confidence Interval) for cardiovascular events for intermediate versus poor 
profile.  
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Figure 4. Association between log hazard ratios of CVD events and age mean at baseline (years). A, ideal 
versus poor profile. B, intermediate versus poor profile. Solid line indicates a linear relationship. Size of each 
data point is proportional to its statistical weight.  
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                        Table 1. Characteristics of included studies. 
Study, year (reference) Country Sample size Mean Age, y Men, % Study name Mean 
follow-up, y 
Main outcome measure Adjusted for 
   Dong et al. 2012  USA 2,981 69.0 36.3 NOMAS study 8.0 Composite variable of 
CVD events, myocardial 
infarction and stroke 
 
Age, sex, and ethnicity 
   Folsom et al. 2011 USA 12,744 54.0 46.4 ARIC study 18.7 Composite variable of 
CVD events and stroke 
Age, sex, and race 
   Folsom et al. 2015 USA 4,855 54.1 46.4 ARIC study 22.5 Heart failure Age, sex, and race 
   Folsom et al. 2015 USA 14,098 54.0 46.4 ARIC study 22.5 Venous 
thromboembolism 
Age, sex, and race 
   Gaye et al. 2017 France 7,371 72.8 36.7 The Three-City Study 9.0 Coronary heart disease 
and stroke 
Age, sex, study site, 
education level, and living 
alone at baseline 
   Kulshreshtha et al. 2013 USA 22,914 65.0 42.0 REGARDS study 4.9 Stroke Age, race, sex, income, 
alcohol use, education, and 
geographic region 
   Lachman et al. 2015 Europe 10,043 57.0 44.1 EPIC-Norfolk Study 10.0 Composite variable of 
CVD events, coronary 
heart disease, and stroke 
Age and sex 
   Miao et al. 2015 China 91,598 51.5 79.5 Kailuan Study 6.8 Composite variable of 
CVD events, myocardial 
infarction, and stroke 
Age, sex, alcohol 
consumption, income, 
education and history of 
cardiovascular disease, heart 
rate, uric acid, and high-
sensitivity CRP 
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   Nayor et al. 2016 USA 2,392 59.0 44.0 Framingham Offspring 
Study 
12.3 Heart failure Age and sex 
   Ogunmoroti et al. 2017 USA 6,506 62.0 47.0 Multi-Ethnic Study of 
Atherosclerosis 
12.2 Heart failure Age, sex, race/ethnicity, 
education, income, and health 
insurance 
   Olson et al. 2015 USA 30,239 69.0 45.0 REGARDS study 5 Venous 
thromboembolism 
Age, sex, income, education, 
race, region, and race x 
region interaction 
   Ommerborn et al. 2016 USA 4,702 54.5 35.0 Jackson Heart Study 8.3 Composite variable of 
CVD events 
Age, sex, income, and 
education 
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MEDLINE (2010- July 2017) 
 Key words  
1 American heart association[MeSH Terms] 
2 american heart association 
3 #1 or #2 
4  "cardiovascular health" 
5 "ideal cardiovascular health" 
6 "life's simple 7" 
7 ideal health metrics 
8 ideal cardiovascular health metrics 
9 #4 or #5 or #6 or #7 or #8 
10 #3 and #9 
11 blood pressure[MeSH Terms] 
12 Pressure, Blood 
13 blood pressure 
14 Systolic Pressure 
15 Pressure, Systolic 
16 Pressures, Systolic 
17 Diastolic Pressure 
18 Pressure, Diastolic 
19 Pulse Pressure 
20 Pressure, Pulse 
21 #11 or #12 or #13 or #14 or #15 or #16 or #17 
or #18 or #19 or #20 
22 Blood glucose[MeSH Terms] 
23 Blood glucose 
24 Blood Sugar 
25 Sugar, Blood 
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28
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32
33
34
35
36
37
38
39
40
41
42
43
44
45
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49
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52
53
54
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57
58
59
60
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26 Glucose, Blood 
27 #22 or #23 or #24 or #25 or #26 
28 Cholesterol[MeSH Terms] 
29 Cholesterol 
30 epicholesterol 
31 #28 or #29 or #30 
32 exercise[MeSH Terms] 
33 exercise 
34 physical fitness[MeSH Terms] 
35 physical fitness 
36 Exercise, Physical 
37 Exercises, Physical 
38 Physical Exercise 
39 #32 or #33 or #34 or #35 or #36 or #37 or #38 
40 diet[MeSH Terms] 
41 diet 
42 diets 
43 #40 or #41 or #42 
44 smoking[MeSH Terms] 
45 smoking 
46 Smokings, Tobacco 
47 Tobacco Smokings 
48 Smoking, Tobacco 
49 #44 or #45 or #46 or #47 or #48 
50 body mass index[MeSH Terms] 
51 body mass index 
52 Index, Body Mass 
53 Quetelet Index 
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26
27
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30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
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49
50
51
52
53
54
55
56
57
58
59
60
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54 Index, Quetelet 
55 Quetelet's Index 
56 Quetelets Index 
57 #50 or #51 or #52 or #53 or #54 or #55 or #56 
58 #21 and #27 and #31 and #39 and #43 and #49 
and #57 
59 cardiovascular disease [MeSH Terms] 
60 event 
61 myocardial infarction [MeSH Terms] 
62 infarction 
63 myocardial 
64 stroke [MeSH Terms] 
65 heart failure [MeSH Terms] 
66 heart  
67 failure 
68 venous thromboembolism [MeSH Terms] 
69 venous 
70 thromboembolism 
71 coronary disease [MeSH Terms] 
72 coronary  
73 peripheral artery disease [MeSH Terms] 
74 peripheral 
75 #59 or #60 or #61 or #62 or #63 or #64 or #65 
or #66 or #67 or #68 or #69 or #70 or #71 or 
#72 or #73 or #74 
78 #75 Filters: Publication date from 2010/01/01 
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 EMBASE (2010- July 2017) 
 Key words 
1  'blood pressure'/exp 
2 blood pressure' 
3 cholesterol'/exp 
4 cholesterol 
5 epicholesterol 
6 glucose blood level'/exp 
7  'blood glucose' 
8  'exercise'/exp 
9 exercise 
10 fitness 
11  'diet'/exp 
12 diet 
13 diets 
14  'body mass'/exp 
15  'body mass index' 
16  'quetelet index' 
17  'somking'/exp 
18 smoking 
19 tobacco 
20  'behavior, smoking' 
21  'smoking behavior' 
22 #1 or #2 
23 #3 or #4 or #5 
24 #6 or #7 
25 #8 or #9 or #10 
26 #11 or #12 or #13 
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27 #14 or #15 or #16 
28 #17 or #18 or #19 or #20 or #21 
29 #22 and #23 and #24 and #25 and #26 and #27 
and #28  
30  'American Heart association' 
31  'Cardiovascular Health' 
32  'Ideal Cardiovascular Health' 
33  'Lifes simple 7' 
34  'Life simple 7' 
35  'Ideal Health Metrics' 
36  'Ideal Cardiovascular Health Metrics' 
37 #31 or #32 or #33 or #34 or #35 or #36 
38 #30 and #37 
39 'cardiovascular disease' 
40 'myocardial infarction' 
41 'stroke' 
42 'heart failure' 
43 'venous thromboembolism' 
44 'coronary disease' 
45 'peripheral artery disease' 
46 #39 or #40 or #41 or #42 or #43 or #44 or #45 
47 #29 or #38 
48 #46 and #47 
49 #46 and #57 and [2010-2017]/py 
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CINAHL (2010- July 2017) 
 Key words 
1 MeSH descriptor: [American Heart Association] 
explode all trees 
2 "American heart association" 
3 #1 or #2 
4 Cardiovascular Health 
5 ideal cardiovascular health 
6 Life’s simple 7 
7 ideal health metrics 
8 ideal cardiovascular health metrics 
9 #4 or #5 or #6 or #7 or #8 
10 #9 and #3 
11 MeSH descriptor: [Blood Pressure] explode all 
trees 
12 blood pressure 
13 Pressure, Blood 
14 Systolic Pressure 
15 Pressure, Systolic 
16 Pressures, Systolic 
17 Diastolic Pressure 
18 Pressure, Diastolic 
19 Pulse Pressure 
20 Pressure, Pulse 
21 #11 or #12 or #13 or #14 or #15 or #16 or #17 
or #18 or #19 or #20 
22 MeSH descriptor: [Blood Glucose] explode all 
trees 
23 blood glucose 
24 Blood Sugar 
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38
39
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41
42
43
44
45
46
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48
49
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53
54
55
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57
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59
60
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25 Sugar, Blood 
26 Glucose, Blood 
27 #22 or #23 or #24 or #25 or #26 
28 MeSH descriptor: [Cholesterol] explode all trees 
29 Cholesterol 
30 Epicholesterol 
31 #28 or #29 or #30 
32 MeSH descriptor: [Exercise] explode all trees 
33 exercise 
34 MeSH descriptor: [Physical Fitness] explode all 
trees 
35 physical fitness 
36 Exercise, Physical 
37 Exercises, Physical 
38 Physical Exercise 
39 #32 or #33 or #34 or #35 or #36 or #37 or #38 
40 MeSH descriptor: [Diet] explode all trees 
41 diet 
42 diets 
43 #40 or #41 or #42 
44 MeSH descriptor: [Body Mass Index] explode 
all trees 
45 body mass index 
46 Index, Body Mass 
47 Quetelet Index 
48 Index, Quetelet 
49 Quetelet's Index 
50 Quetelets Index 
51 #44 or #45 or #46 or #47 or #48 or #49  
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52 MeSH descriptor: [Smoking] explode all trees 
53 smoking 
54 Smokings, Tobacco 
55 Tobacco Smokings 
56 Smoking, Tobacco 
57 #52 or #53  or #56 
58 #21 and #27 and #31 and #39 and #43 and #51 
and #57 
59 #10 or #58 
60 MeSH descriptor: [cardiovascular disease] 
explode all trees 
61 'cardiovascular disease' 
62 'myocardial infarction' 
63 'stroke' 
64 'heart failure' 
65 'venous thromboembolism' 
66 'coronary disease' 
67 'peripheral artery disease' 
75 #60 or #61 or #62 or #63 or #64 or #65 or #66 
or #67 
84 #59 and #75 Publication Year from 2010 to 
2017 
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Figure S1. Prevalence of ideal levels for each of the 7 metrics of cardiovascular health 
at baseline. Favorable health behaviors: smoking abstention in the last year, ideal body 
mass index, physical activity and consumption of a diet that promotes cardiovascular 
health; and health factors: untreated total cholesterol< 200 mg/dl, untreated blood 
pressure <120/80 mm/Hg, and absence of diabetes mellitus. BMI, body mass index; BP, 
blood pressure; PA, physical activity; TC, total cholesterol. 
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Figure S2. Funnel plots for log hazard ratios of CVD events for ideal (A) and 
intermediate profile (B). 
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